FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 51 through 100 of 278

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
CDT Nasdaq Conduit Pharmaceuticals Inc. 2830
CGC Nasdaq Canopy Growth Corporation 2830
CGEM Nasdaq Cullinan Therapeutics, Inc. 2830
CHRO NYSE American Channel Therapeutics Corporation 2830
CING Nasdaq Cingulate Inc. 2830
CLDI NYSE American Calidi Biotherapeutics, Inc. 2830
CLDX Nasdaq Celldex Therapeutics, Inc. 2830
CLRB Nasdaq Cellectar Biosciences, Inc. 2830
CLSD Nasdaq Clearside Biomedical, Inc. 2830
CLVLY Over the counter Clinuvel Pharmaceuticals Limited 2830
CMND Nasdaq Clearmind Medicine Inc. 2830
CNSP Nasdaq CNS Pharmaceuticals, Inc. 2830
CNTX Nasdaq Context Therapeutics Inc. 2830
COLL Nasdaq Collegium Pharmaceutical, Inc. 2830
CORT Nasdaq Corcept Therapeutics Incorporated 2830
CRBU Nasdaq Caribou Biosciences, Inc. 2830
CRL New York Charles River Laboratories International 2830
CRMD Nasdaq CorMedix Inc. 2830
CRON Nasdaq Cronos Group Inc. 2830
CRSP Nasdaq CRISPR Therapeutics AG 2830
CSCI Nasdaq COSCIENS Biopharma Inc. 2830
CSLLY Over the counter CSL Limited 2830
CTMX Nasdaq CytomX Therapeutics, Inc. 2830
CTNM Nasdaq Contineum Therapeutics, Inc. 2830
CTOR Nasdaq Citius Oncology, Inc. 2830
CUPR Nasdaq Cuprina Holdings (Cayman) Limited 2830
CVKD Nasdaq Cadrenal Therapeutics, Inc. 2830
CVM NYSE American CEL-SCI Corporation 2830
CYCC Nasdaq Cyclacel Pharmaceuticals, Inc. 2830
CYCN Nasdaq Cyclerion Therapeutics, Inc. 2830
CYTK Nasdaq Cytokinetics, Incorporated 2830
DNLI Nasdaq Denali Therapeutics Inc. 2830
DVAX Nasdaq Dynavax Technologies Corporation 2830
DWTX Nasdaq Dogwood Therapeutics, Inc. 2830
EBS New York Emergent BioSolutions Inc. 2830
ELAN New York Elanco Animal Health Incorporated 2830
ENLV Nasdaq Enlivex Therapeutics Ltd. 2830
ENSC Nasdaq Ensysce Biosciences, Inc. 2830
ENTO Nasdaq Entero Therapeutics, Inc. 2830
EPRX Nasdaq Eupraxia Pharmaceuticals Inc. 2830
ESLA Nasdaq Estrella Immunopharma, Inc. 2830
EVAX Nasdaq Evaxion A/S 2830
EVO Nasdaq Evotec SE 2830
EVOK Nasdaq Evoke Pharma, Inc. 2830
EWTX Nasdaq Edgewise Therapeutics, Inc. 2830
EXEL Nasdaq Exelixis, Inc. 2830
EXOZ Nasdaq eXoZymes, Inc. 2830
EYEN Nasdaq Eyenovia, Inc. 2830
EYPT Nasdaq EyePoint Pharmaceuticals, Inc. 2830
FDMT Nasdaq 4D Molecular Therapeutics, Inc. 2830
Results 50 through 100 of 278